RMC No. 123-2024: Clarification on the Three-Year Validity of Certificates of Tax Exemption for Certain Corporations

RMC No. 123-2024 clarifies that the three-year validity of Certificates of Tax Exemption does not apply to certain corporations and retirement plans; affected entities must verify and revalidate CTEs if necessary. Corporations and tax practitioners need to act now to ensure compliance: not all Certificates of Tax Exemption (CTEs) issued under prior rules automatically enjoy […]

RMC No. 9-2024: Disregard Surcharge on Amended eFPS Tax Returns to Pay Only Basic Tax, Interest, and Compromise

RMC No. 9-2024 clarifies that taxpayers filing amended returns via eFPS should disregard system-computed surcharges and pay only basic tax, interest, and compromise if the original return was timely filed. Businesses and taxpayers using the Bureau of Internal Revenue’s electronic Filing and Payment System (eFPS) need to take immediate note: when filing amended tax returns […]

RMC No. 156-2022: Updates to VAT-Exempt Medicines List for Common and Chronic Illnesses

RMC No. 156-2022 updates the VAT-exempt medicines list under the CREATE Act, covering chronic and life-threatening conditions. Businesses must adjust VAT calculations immediately. Businesses and healthcare providers must now adjust their VAT calculations immediately for certain medicines prescribed for hypertension, diabetes, high cholesterol, tuberculosis, mental illness, and cancer. The Food and Drug Administration’s latest update, […]